Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune control of cytomegalovirus reactivation in stem cell transplantation
Mariapia A. Degli‐Esposti, Geoffrey R. Hill
Blood (2021) Vol. 139, Iss. 9, pp. 1277-1288
Open Access | Times Cited: 19

Showing 19 citing articles:

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
Masumi Ueda, Hu Xie, Danniel Zamora, et al.
Blood Advances (2023) Vol. 7, Iss. 8, pp. 1394-1403
Open Access | Times Cited: 14
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia
Yu Akahoshi, Hideki Nakasone, Katsuto Takenaka, et al.
Blood Advances (2023) Vol. 7, Iss. 12, pp. 2699-2708
Open Access | Times Cited: 11
IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation
Ping Zhang, Peter Fleming, Christopher E. Andoniou, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 7
Open Access | Times Cited: 4
Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide database
Yuichi Ishikawa, Kei Tokutsu, Shingo Nakayamada, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 103-111
Closed Access | Times Cited: 9
Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis
Corinna La Rosa, Ibrahim Aldoss, Yoonsuh Park, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 4, pp. 588-597
Open Access | Times Cited: 7
Recent Advancements in Poor Graft Function Following Hematopoietic Stem Cell Transplantation
Yan Gao Man, Zhixiang Lu, Xiangmei Yao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
Ying-Jun Chang, Xiaosu Zhao, Xiao‐Jun Huang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 15
CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis
Chris D. Lauruschkat, Ihsan Muchsin, A Rein, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Antigen-specific γδ T cells contribute to cytomegalovirus control after stem cell transplantation
Immo Prinz, Christian Koenecke
Current Opinion in Immunology (2023) Vol. 82, pp. 102303-102303
Open Access | Times Cited: 4
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial
Xin Xu, Zhiping Fan, Yu Wang, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Attenuated humoral response against SARS‐CoV‐2 mRNA vaccination in allogeneic stem cell transplantation recipients
Takashi Toya, Yuya Atsuta, Takahiro Sanada, et al.
Cancer Science (2022) Vol. 114, Iss. 2, pp. 586-595
Open Access | Times Cited: 6
Licensing Natural Killers for Antiviral Immunity
John M. Cronk, Eleni Fafoutis, Michael G. Brown
Pathogens (2021) Vol. 10, Iss. 7, pp. 908-908
Open Access | Times Cited: 5
Mycophenolate mofetil is associated with inferior overall survival in cytomegalovirus seropositive patients with acute myeloid leukemia undergoing hematopoietic cell transplantation
Rima M. Saliba, Stephanie J. Lee, Paul A. Carpenter, et al.
Haematologica (2024)
Open Access
Drug evaluation: maribavir as a cytomegalovirus antiviral agent
Alan Koff, Maricar Malinis
Future Virology (2024), pp. 1-13
Closed Access
Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
Jessica Gill, Davide Stella, Irene Dogliotti, et al.
Hemato (2023) Vol. 4, Iss. 2, pp. 158-169
Open Access
Comparative analysis of hematology parameters after Human cytomegalovirus infection in children of different ages
Yingying Wang, Zheng Zhou, Lijuan Kan, et al.
Authorea (Authorea) (2023)
Open Access
Cytomegalovirus reactivation under pre-emptive therapy following allogeneic hematopoietic stem cell transplant: Pattern, survival, and risk factors in the Republic of Korea
Ka‐Won Kang, Min Ji Jeon, Eun Sang Yu, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291268-e0291268
Open Access
Cytomegalovirus-specific T cell immunity reconstitution following allogeneic hematopoietic stem cell transplantation: a pilot stduy
Luxiang Wang, Li Su, Jiayu Huang, et al.
Research Square (Research Square) (2023)
Open Access
Risk Factors Associated with Survival Following Ganciclovir Prophylaxis through Day +100 in Cytomegalovirus At-Risk Pediatric Allogeneic Stem Cell Transplantation Recipients: Development of Cytomegalovirus Viremia Associated with Significantly Decreased 1-Year Survival
Liana Klejmont, Xiaokui Mo, Jordan Milner, et al.
Transplantation and Cellular Therapy (2023) Vol. 30, Iss. 1, pp. 103.e1-103.e8
Open Access
Page 1

Scroll to top